0.8076
price down icon5.00%   -0.0425
 
loading
Io Biotech Inc stock is traded at $0.8076, with a volume of 333.84K. It is down -5.00% in the last 24 hours and down -1.79% over the past month. IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
See More
Previous Close:
$0.8501
Open:
$0.86
24h Volume:
333.84K
Relative Volume:
0.09
Market Cap:
$58.11M
Revenue:
-
Net Income/Loss:
$-86.08M
P/E Ratio:
-0.3743
EPS:
-2.1574
Net Cash Flow:
$-72.06M
1W Performance:
+15.92%
1M Performance:
-1.79%
6M Performance:
-46.16%
1Y Performance:
+2.00%
1-Day Range:
Value
$0.80
$0.8622
1-Week Range:
Value
$0.6903
$0.88
52-Week Range:
Value
$0.3234
$2.79

Io Biotech Inc Stock (IOBT) Company Profile

Name
Name
Io Biotech Inc
Name
Phone
(457) 070-2980
Name
Address
OLE MAALOES VEH 3, COPENHAGEN
Name
Employee
78
Name
Twitter
Name
Next Earnings Date
2025-08-08
Name
Latest SEC Filings
Name
IOBT's Discussions on Twitter

Compare IOBT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IOBT
Io Biotech Inc
0.8076 61.16M 0 -86.08M -72.06M -2.1574
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Io Biotech Inc Stock (IOBT) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-30-25 Downgrade Morgan Stanley Overweight → Equal-Weight
Sep-30-25 Downgrade TD Cowen Buy → Hold

Io Biotech Inc Stock (IOBT) Latest News

pulisher
05:51 AM

IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat

05:51 AM
pulisher
Dec 13, 2025

IO Biotech (NASDAQ:IOBT) Stock Rating Lowered by Wall Street Zen - MarketBeat

Dec 13, 2025
pulisher
Dec 08, 2025

Nothing is Better Than IO Biotech Inc (IOBT) stock at the moment - Setenews

Dec 08, 2025
pulisher
Dec 05, 2025

What margin trends mean for IO Biotech Inc stock2025 Winners & Losers & AI Powered Trade Plan Recommendations - BỘ NỘI VỤ

Dec 05, 2025
pulisher
Dec 02, 2025

IO Biotech (IOBT) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Dec 01, 2025

How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews

Dec 01, 2025
pulisher
Nov 27, 2025

Will IO Biotech Inc. stock reach all time highs in 2025July 2025 Levels & Growth Focused Stock Reports - moha.gov.vn

Nov 27, 2025
pulisher
Nov 27, 2025

Research Recommendations For IO Biotech Inc (IOBT): Here is What You Should Know - fostersleader.com

Nov 27, 2025
pulisher
Nov 27, 2025

Analyst Downgrade: How IO Biotech Inc. stock benefits from strong dollarJuly 2025 Movers & Free Growth Oriented Trading Recommendations - moha.gov.vn

Nov 27, 2025
pulisher
Nov 26, 2025

How strong is IO Biotech Inc. stock balance sheetMarket Performance Recap & Long-Term Safe Investment Plans - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 26, 2025

Aug Wrap: What margin trends mean for IO Biotech Inc. stockJuly 2025 Decliners & Real-Time Volume Analysis Alerts - moha.gov.vn

Nov 26, 2025
pulisher
Nov 26, 2025

IO Biotech Announces Participation in Upcoming December Investor Conferences - The Manila Times

Nov 26, 2025
pulisher
Nov 26, 2025

IO Biotech (Nasdaq: IOBT) to Join Evercore, Piper Sandler December Investor Events - Stock Titan

Nov 26, 2025
pulisher
Nov 24, 2025

IOBTRemeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - mx.advfn.com

Nov 24, 2025
pulisher
Nov 24, 2025

It makes sense and dollars to buy IO Biotech Inc (IOBT) stock - Setenews

Nov 24, 2025
pulisher
Nov 23, 2025

Ligand Pharmaceuticals (NASDAQ:LGND) and IO Biotech (NASDAQ:IOBT) Financial Review - Defense World

Nov 23, 2025
pulisher
Nov 23, 2025

IO Biotech (NASDAQ:IOBT) Stock Rating Upgraded by Wall Street Zen - Defense World

Nov 23, 2025
pulisher
Nov 22, 2025

IO Biotech announces resignation of chief accounting officer and new appointment - Investing.com Australia

Nov 22, 2025
pulisher
Nov 21, 2025

IO Biotech Announces Resignation of Chief Accounting Officer - MSN

Nov 21, 2025
pulisher
Nov 21, 2025

IO Biotech announces resignation of chief accounting officer and new appointment By Investing.com - Investing.com South Africa

Nov 21, 2025
pulisher
Nov 21, 2025

IO Biotech Announces Management Changes - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

[8-K] IO Biotech, Inc. Reports Material Event | IOBT SEC FilingForm 8-K - Stock Titan

Nov 21, 2025
pulisher
Nov 21, 2025

IO Biotech, Inc. Announces Executive Changes - MarketScreener

Nov 21, 2025
pulisher
Nov 21, 2025

Can IO Biotech Inc. stock withstand economic slowdown2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - The Spec

Nov 20, 2025
pulisher
Nov 19, 2025

Piper Sandler reiterates Overweight rating on IO Biotech stock By Investing.com - Investing.com South Africa

Nov 19, 2025
pulisher
Nov 19, 2025

Is IO Biotech Inc. stock entering bullish territoryJuly 2025 Review & Fast Gaining Stock Reports - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is IO Biotech Inc. stock a top momentum playWeekly Stock Analysis & Daily Price Action Insights - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why - Yahoo Finance

Nov 19, 2025
pulisher
Nov 19, 2025

Will IO Biotech Inc. stock deliver long term returns2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Piper Sandler reiterates Overweight rating on IO Biotech stock - Investing.com India

Nov 19, 2025
pulisher
Nov 19, 2025

IO Biotech Inc. (IOBT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 19, 2025
pulisher
Nov 19, 2025

Is IO Biotech Inc. stock safe for conservative investorsPortfolio Return Summary & Reliable Volume Spike Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

IO Biotech Presents at Jefferies Global Healthcare Conference - MSN

Nov 18, 2025
pulisher
Nov 18, 2025

IO Biotech Inc (IOBT) is looking forward to a strong quarter - Setenews

Nov 18, 2025
pulisher
Nov 18, 2025

IO Biotech, Inc. Updates on Cylembio Phase 3 Trial Results - TradingView

Nov 18, 2025
pulisher
Nov 18, 2025

Will IO Biotech Inc. see short term momentum2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 17, 2025

Sector ETF performance correlation with IO Biotech Inc.Market Trend Review & Smart Allocation Stock Reports - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Is IO Biotech Inc. meeting your algorithmic filter criteriaEarnings Miss & High Conviction Investment Ideas - newser.com

Nov 17, 2025
pulisher
Nov 15, 2025

What moving averages say about IO Biotech Inc.Stock Surge & Low Risk High Reward Trade Ideas - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

IO Biotech’s Hold Rating Amid Financial and Regulatory Uncertainty - TipRanks

Nov 15, 2025
pulisher
Nov 15, 2025

Will IO Biotech Inc. stock outperform tech sector in 2025Bull Run & Weekly High Momentum Picks - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

IO Biotech, Inc.Common Stock (Nasdaq:IOBT) Detailed Stock Data | PRN_FinancialWrapper | PR Newswire - Markets Financial Content

Nov 14, 2025

Io Biotech Inc Stock (IOBT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Cap:     |  Volume (24h):